Skip to main content
Erschienen in:

18.05.2022 | Review

Update on the Diagnosis and Treatment of Achalasia

verfasst von: Wojciech Blonski, Samuel Slone, Joel E. Richter

Erschienen in: Dysphagia | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Achalasia is a rare disease of the esophagus with impaired relaxation of the lower esophageal sphincter and aperistalsis. The etiology is unknown but speculations include a viral or autoimmune etiology. All specialists dealing with swallowing and esophageal diseases should recognize the classic symptoms of dysphagia for solids/liquids, regurgitation, and choking, especially at night. High-resolution manometry is critical for the diagnosis with endoscopy and barium esophagram having a supportive role. The disease cannot be cured but most can return to near normal swallowing and a regular diet with appropriate therapy. Treatment includes smooth muscle relaxants, botulinum toxin injections to the lower sphincter, pneumatic dilation, Heller myotomy, and peroral endoscopic myotomy. One treatment does not fit all and a tailored approach through a multidiscipline team will give the best long-term outcomes.
Literatur
1.
Zurück zum Zitat Boeckxstaens GE, Zanitto G, Richter JE. Achaslasia. Lancet. 2014;383:89–93.CrossRef Boeckxstaens GE, Zanitto G, Richter JE. Achaslasia. Lancet. 2014;383:89–93.CrossRef
2.
Zurück zum Zitat Samo S, Carlsen DA, Gregory DL, et al. Incidence and prevalence of achalasia in central Chicago, 2004–2014, since widespread use of high resolution manometry. Clin Gastroenterol Hepatol. 2017;15:366–73.PubMedCrossRef Samo S, Carlsen DA, Gregory DL, et al. Incidence and prevalence of achalasia in central Chicago, 2004–2014, since widespread use of high resolution manometry. Clin Gastroenterol Hepatol. 2017;15:366–73.PubMedCrossRef
3.
Zurück zum Zitat Park W, Vaezi MF. Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol. 2005;100(6):1404–14.PubMedCrossRef Park W, Vaezi MF. Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol. 2005;100(6):1404–14.PubMedCrossRef
4.
Zurück zum Zitat Mearin F, Mourelle M, Guarner F, et al. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest. 1993;23(11):724–8.PubMedCrossRef Mearin F, Mourelle M, Guarner F, et al. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest. 1993;23(11):724–8.PubMedCrossRef
5.
Zurück zum Zitat Aggestrup S, Uddman R, Jensen SL, et al. Regulatory peptides in the lower esophageal sphincter of man. Regul Pept. 1985;10(2–3):167–78.PubMedCrossRef Aggestrup S, Uddman R, Jensen SL, et al. Regulatory peptides in the lower esophageal sphincter of man. Regul Pept. 1985;10(2–3):167–78.PubMedCrossRef
6.
Zurück zum Zitat Dodds WJ, Dent J, Hogan WJ, Patel GK, Toouli J, Arndorfer RC. Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia. Gastroenterology. 1981;80(2):327–33.PubMedCrossRef Dodds WJ, Dent J, Hogan WJ, Patel GK, Toouli J, Arndorfer RC. Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia. Gastroenterology. 1981;80(2):327–33.PubMedCrossRef
7.
Zurück zum Zitat de Oliveira RB, RezendeFilho J, Dantas RO, Iazigi N. The spectrum of esophageal motor disorders in Chagas’ disease. Am J Gastroenterol. 1995;90(7):1119–24.PubMed de Oliveira RB, RezendeFilho J, Dantas RO, Iazigi N. The spectrum of esophageal motor disorders in Chagas’ disease. Am J Gastroenterol. 1995;90(7):1119–24.PubMed
8.
Zurück zum Zitat Sodikoff JB, Lo AA, Shetuni BB, Kahrilas PJ, Yang GY, Pandolfino JE. Histopathologic patterns among achalasia subtypes. Neurogastroenterol Motil. 2016;28(1):139–45.PubMedCrossRef Sodikoff JB, Lo AA, Shetuni BB, Kahrilas PJ, Yang GY, Pandolfino JE. Histopathologic patterns among achalasia subtypes. Neurogastroenterol Motil. 2016;28(1):139–45.PubMedCrossRef
9.
Zurück zum Zitat Jones DB, Mayberry JF, Rhodes J, Munro J. Preliminary report of an association between measles virus and achalasia. J Clin Pathol. 1983;36(6):655–7.PubMedPubMedCentralCrossRef Jones DB, Mayberry JF, Rhodes J, Munro J. Preliminary report of an association between measles virus and achalasia. J Clin Pathol. 1983;36(6):655–7.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Naik RD, Vaezi MF, Gerskon AA et al. Association of achalasia with active varicella zoster infection of the esophagus. Gastroenterol 2021 Naik RD, Vaezi MF, Gerskon AA et al. Association of achalasia with active varicella zoster infection of the esophagus. Gastroenterol 2021
11.
Zurück zum Zitat Furuzawa-Carballeda J, Aguilar-Leon D, Gamboa-Dominguez A, et al. Achalasia–an autoimmune inflammatory disease: a cross-sectional study. J Immunol Res. 2015;2015:729217.PubMedPubMedCentralCrossRef Furuzawa-Carballeda J, Aguilar-Leon D, Gamboa-Dominguez A, et al. Achalasia–an autoimmune inflammatory disease: a cross-sectional study. J Immunol Res. 2015;2015:729217.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Wong RK, Maydonovitch CL, Metz SJ, Baker JR Jr. Significant DQw1 association in achalasia. Dig Dis Sci. 1989;34(3):349–52.PubMedCrossRef Wong RK, Maydonovitch CL, Metz SJ, Baker JR Jr. Significant DQw1 association in achalasia. Dig Dis Sci. 1989;34(3):349–52.PubMedCrossRef
13.
Zurück zum Zitat De la Concha EG, Fernandez-Arquero M, Mendoza JL, et al. Contribution of HLA class II genes to susceptibility in achalasia. Tissue Antigens. 1998;52(4):381–4.PubMedCrossRef De la Concha EG, Fernandez-Arquero M, Mendoza JL, et al. Contribution of HLA class II genes to susceptibility in achalasia. Tissue Antigens. 1998;52(4):381–4.PubMedCrossRef
14.
Zurück zum Zitat Verne GN, Hahn AB, Pineau BC, Hoffman BJ, Wojciechowski BW, Wu WC. Association of HLA-DR and -DQ alleles with idiopathic achalasia. Gastroenterology. 1999;117(1):26–31.PubMedCrossRef Verne GN, Hahn AB, Pineau BC, Hoffman BJ, Wojciechowski BW, Wu WC. Association of HLA-DR and -DQ alleles with idiopathic achalasia. Gastroenterology. 1999;117(1):26–31.PubMedCrossRef
15.
Zurück zum Zitat Gockel I, Becker J, Wouters MM, et al. Common variants in the HLA-DQ region confer susceptibility to idiopathic achalasia. Nat Genet. 2014;46(8):901–4.PubMedCrossRef Gockel I, Becker J, Wouters MM, et al. Common variants in the HLA-DQ region confer susceptibility to idiopathic achalasia. Nat Genet. 2014;46(8):901–4.PubMedCrossRef
16.
Zurück zum Zitat Booy JD, Takata J, Tomlinson G, Urbach DR. The prevalence of autoimmune disease in patients with esophageal achalasia. Dis Esophagus. 2012;25(3):209–13.PubMedCrossRef Booy JD, Takata J, Tomlinson G, Urbach DR. The prevalence of autoimmune disease in patients with esophageal achalasia. Dis Esophagus. 2012;25(3):209–13.PubMedCrossRef
17.
Zurück zum Zitat Ruiz-de-Leon A, Mendoza J, Sevilla-Mantilla C, et al. Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci. 2002;47(1):15–9.PubMedCrossRef Ruiz-de-Leon A, Mendoza J, Sevilla-Mantilla C, et al. Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci. 2002;47(1):15–9.PubMedCrossRef
18.
Zurück zum Zitat King D, Thomas T, Chandan JS, et al. Achalasia is associated with atopy in patients younger than 40 years of age. Am J Gastroenterol. 2021;116(2):416–9.PubMedCrossRef King D, Thomas T, Chandan JS, et al. Achalasia is associated with atopy in patients younger than 40 years of age. Am J Gastroenterol. 2021;116(2):416–9.PubMedCrossRef
21.
Zurück zum Zitat Eckardt V, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology. 1992;103:1732–8.PubMedCrossRef Eckardt V, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology. 1992;103:1732–8.PubMedCrossRef
22.
Zurück zum Zitat Urbach DR, Tomlinson G, Harnish JG. A measure of disease-specific health related quality of life for achalasia. Am J Gastroenterol. 2005;100:1668–76.PubMedCrossRef Urbach DR, Tomlinson G, Harnish JG. A measure of disease-specific health related quality of life for achalasia. Am J Gastroenterol. 2005;100:1668–76.PubMedCrossRef
23.
Zurück zum Zitat Slone S, Kumar A, Jacobs J, Velanovich V. Richter JE. Accuracy of achalasia quality of life and Eckardt scores for assessment of clinical improvement post treatment for achalasia. Dis Esophagus 2020 https://doi.org/10.1092/doaa080 Slone S, Kumar A, Jacobs J, Velanovich V. Richter JE. Accuracy of achalasia quality of life and Eckardt scores for assessment of clinical improvement post treatment for achalasia. Dis Esophagus 2020 https://​doi.​org/​10.​1092/​doaa080
24.
Zurück zum Zitat ASGE Standards and Practice Committee, Patria SF, Acosta R, et al. The role of endoscopy in the evaluation and management of achalasia. Gastrointestinal Endosc. 2014;79:191–201.CrossRef ASGE Standards and Practice Committee, Patria SF, Acosta R, et al. The role of endoscopy in the evaluation and management of achalasia. Gastrointestinal Endosc. 2014;79:191–201.CrossRef
25.
Zurück zum Zitat Levine MS, Rubesin SE, Laufler IL. Barium studies in modern radiology. Do they have a role? Radiology. 2009;250:18–22.PubMedCrossRef Levine MS, Rubesin SE, Laufler IL. Barium studies in modern radiology. Do they have a role? Radiology. 2009;250:18–22.PubMedCrossRef
26.
Zurück zum Zitat Howard PJ, Maker G, Pryde A, et al. Five year prospective study of the incidence, clinical features and diagnosis of achalasia in Edinburg. Gut. 1992;33:1011–5.PubMedPubMedCentralCrossRef Howard PJ, Maker G, Pryde A, et al. Five year prospective study of the incidence, clinical features and diagnosis of achalasia in Edinburg. Gut. 1992;33:1011–5.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Slone S. Kumar A, Richter JE. Community approach to the diagnosis of achalasia: High resolution manometry is helping but needs to be earlier than later. DDW 2021. Slone S. Kumar A, Richter JE. Community approach to the diagnosis of achalasia: High resolution manometry is helping but needs to be earlier than later. DDW 2021.
28.
Zurück zum Zitat Pandolfino JE, Fox MR, Bredenoord AJ, Kahrilas PJ. High-resolution manometry in clinical practice: utilizing pressure topography to classify oesophageal motility abnormalities. Neurogastroenterol Motil. 2009;21(8):796–806.PubMedPubMedCentralCrossRef Pandolfino JE, Fox MR, Bredenoord AJ, Kahrilas PJ. High-resolution manometry in clinical practice: utilizing pressure topography to classify oesophageal motility abnormalities. Neurogastroenterol Motil. 2009;21(8):796–806.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Bredenoord AJ, Fox M, Kahrilas PJ, et al. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil. 2012;24(Suppl 1):57–65.PubMedPubMedCentralCrossRef Bredenoord AJ, Fox M, Kahrilas PJ, et al. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil. 2012;24(Suppl 1):57–65.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160–74.PubMedCrossRef Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160–74.PubMedCrossRef
31.
Zurück zum Zitat Yadlapati R, Kahrilas PJ, Fox MR, et al. Esophageal motility disorders on high-resolution manometry: chicago classification version 4.0((c)). Neurogastroenterol Motil. 2021;33(1):e14058.PubMedPubMedCentralCrossRef Yadlapati R, Kahrilas PJ, Fox MR, et al. Esophageal motility disorders on high-resolution manometry: chicago classification version 4.0((c)). Neurogastroenterol Motil. 2021;33(1):e14058.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Chavez YH, Ciarleglio MM, Clarke JO, et al. Upper esophageal abnormalities. Frequent finding on high resolution esophageal manometry and associated with poorer treatment response in achalasia. J Clin Gastroenterol. 2015;49:17–23.PubMedCrossRef Chavez YH, Ciarleglio MM, Clarke JO, et al. Upper esophageal abnormalities. Frequent finding on high resolution esophageal manometry and associated with poorer treatment response in achalasia. J Clin Gastroenterol. 2015;49:17–23.PubMedCrossRef
33.
Zurück zum Zitat Yoneyama F, Miyacki M, Nimura Y. Manometric findings of the upper esophageal sphincter in esophageal achalasia. World J Surg. 1998;22:1043–6.PubMedCrossRef Yoneyama F, Miyacki M, Nimura Y. Manometric findings of the upper esophageal sphincter in esophageal achalasia. World J Surg. 1998;22:1043–6.PubMedCrossRef
34.
Zurück zum Zitat Richter JE. The diagnosis and misdiagnosis of achalasia: it does not have to be so difficult. Clin Gastroenterol Hepatol. 2011;9(12):1010–1.PubMedCrossRef Richter JE. The diagnosis and misdiagnosis of achalasia: it does not have to be so difficult. Clin Gastroenterol Hepatol. 2011;9(12):1010–1.PubMedCrossRef
35.
Zurück zum Zitat de Oliveira JM, Birgisson S, Doinoff C, et al. Timed barium swallow: a simple technique for evaluating esophageal emptying in patients with achalasia. AJR Am J Roentgenol. 1997;169(2):473–9.PubMedCrossRef de Oliveira JM, Birgisson S, Doinoff C, et al. Timed barium swallow: a simple technique for evaluating esophageal emptying in patients with achalasia. AJR Am J Roentgenol. 1997;169(2):473–9.PubMedCrossRef
36.
Zurück zum Zitat Blonski W, Kumar A, Feldman J, Richter JE. Timed barium swallow: diagnostic role and predictive value in untreated achalasia, esophagogastric junction outflow obstruction, and non-achalasia dysphagia. Am J Gastroenterol. 2018;113(2):196–203.PubMedCrossRef Blonski W, Kumar A, Feldman J, Richter JE. Timed barium swallow: diagnostic role and predictive value in untreated achalasia, esophagogastric junction outflow obstruction, and non-achalasia dysphagia. Am J Gastroenterol. 2018;113(2):196–203.PubMedCrossRef
37.
Zurück zum Zitat Zaninotto G, Bennett C, Boeckxstaens G, et al. the 2018 ISDE achalasia guidelines. Dis Esophagus. 2018;31:1–29.CrossRef Zaninotto G, Bennett C, Boeckxstaens G, et al. the 2018 ISDE achalasia guidelines. Dis Esophagus. 2018;31:1–29.CrossRef
38.
Zurück zum Zitat Vaezi MF, Baker ME, Achkar E, Richter JE. Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment. Gut. 2002;50(6):765–70.PubMedPubMedCentralCrossRef Vaezi MF, Baker ME, Achkar E, Richter JE. Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment. Gut. 2002;50(6):765–70.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Blonski W, Kumar A, Feldman J, Richter JE. Timed barium swallow for assessing long-term treatment response in patients with achalasia: Absolute cutoff versus percent change - A cross-sectional analytic study. Neurogastroenterol Motil 2020:e14005. Blonski W, Kumar A, Feldman J, Richter JE. Timed barium swallow for assessing long-term treatment response in patients with achalasia: Absolute cutoff versus percent change - A cross-sectional analytic study. Neurogastroenterol Motil 2020:e14005.
40.
Zurück zum Zitat Rohof WO, Hirsch DP, Kessing BF, Boeckxstaens GE. Efficacy of treatment for patients with achalasia depends on the distensibility of the esophagogastric junction. Gastroenterology. 2012;143(2):328–35.PubMedCrossRef Rohof WO, Hirsch DP, Kessing BF, Boeckxstaens GE. Efficacy of treatment for patients with achalasia depends on the distensibility of the esophagogastric junction. Gastroenterology. 2012;143(2):328–35.PubMedCrossRef
41.
Zurück zum Zitat Kwiatek MA, Pandolfino JE, Hirano I, Kahrilas PJ. Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP). Gastrointest Endosc. 2010;72(2):272–8.PubMedPubMedCentralCrossRef Kwiatek MA, Pandolfino JE, Hirano I, Kahrilas PJ. Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP). Gastrointest Endosc. 2010;72(2):272–8.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Carlson DA, Lin Z, Rogers MC, Lin CY, Kahrilas PJ, Pandolfino JE. Utilizing functional lumen imaging probe topography to evaluate esophageal contractility during volumetric distention: a pilot study. Neurogastroenterol Motil. 2015;27(7):981–9.PubMedPubMedCentralCrossRef Carlson DA, Lin Z, Rogers MC, Lin CY, Kahrilas PJ, Pandolfino JE. Utilizing functional lumen imaging probe topography to evaluate esophageal contractility during volumetric distention: a pilot study. Neurogastroenterol Motil. 2015;27(7):981–9.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Pandolfino JE, de Ruigh A, Nicodeme F, Xiao Y, Boris L, Kahrilas PJ. Distensibility of the esophagogastric junction assessed with the functional lumen imaging probe (FLIP) in achalasia patients. Neurogastroenterol Motil. 2013;25(6):496–501.PubMedPubMedCentralCrossRef Pandolfino JE, de Ruigh A, Nicodeme F, Xiao Y, Boris L, Kahrilas PJ. Distensibility of the esophagogastric junction assessed with the functional lumen imaging probe (FLIP) in achalasia patients. Neurogastroenterol Motil. 2013;25(6):496–501.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Ponds FA, Bredenoord AJ, Kessing BF, Smout AJ. Esophagogastric junction distensibility identifies achalasia subgroup with manometrically normal esophagogastric junction relaxation. Neurogastroenterol Motil 2017;29(1). Ponds FA, Bredenoord AJ, Kessing BF, Smout AJ. Esophagogastric junction distensibility identifies achalasia subgroup with manometrically normal esophagogastric junction relaxation. Neurogastroenterol Motil 2017;29(1).
46.
Zurück zum Zitat Wen ZH, Gardner E, Wang YP. Nitrates for achalasia. Cochrane database of systematic reviews. 2004; CD002299 Wen ZH, Gardner E, Wang YP. Nitrates for achalasia. Cochrane database of systematic reviews. 2004; CD002299
47.
Zurück zum Zitat Prakash C, Freeland KE, Chan ME, Clause RE. Botulinum toxin injections for achalasia symptoms can approximate the short term efficacy of a single pneumatic dilation: a survival analysis approach. Am J Gastroenterol. 1999;94:328–33.PubMedCrossRef Prakash C, Freeland KE, Chan ME, Clause RE. Botulinum toxin injections for achalasia symptoms can approximate the short term efficacy of a single pneumatic dilation: a survival analysis approach. Am J Gastroenterol. 1999;94:328–33.PubMedCrossRef
48.
Zurück zum Zitat Renske AB, Nijhuis O, Prius LT, et al. Factors associated with achalasia treatments outcomes: systematic review and meta-analysis. Clinical Gastroenterol Hepatol. 2021;18:1442–53. Renske AB, Nijhuis O, Prius LT, et al. Factors associated with achalasia treatments outcomes: systematic review and meta-analysis. Clinical Gastroenterol Hepatol. 2021;18:1442–53.
49.
Zurück zum Zitat Vaezi MF, Pandolfino JE, Yadlapati RH, Greer KB, Kavitt RT. ACG Clinical guidelines: diagnosis and management of Achalasia. Am J Gastroenterol. 2020;115(9):1393–411.PubMedPubMedCentralCrossRef Vaezi MF, Pandolfino JE, Yadlapati RH, Greer KB, Kavitt RT. ACG Clinical guidelines: diagnosis and management of Achalasia. Am J Gastroenterol. 2020;115(9):1393–411.PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Richter JE, Boeckxstaens GE. Management of achalasia: surgery or pneumatic dilation. Gut. 2011;60(6):869–76.PubMedCrossRef Richter JE, Boeckxstaens GE. Management of achalasia: surgery or pneumatic dilation. Gut. 2011;60(6):869–76.PubMedCrossRef
51.
Zurück zum Zitat Richter JE. Update on the management of achalasia: balloons, surgery and drugs. Expert Rev Gastroenterol Hepatol. 2008;2(3):435–45.PubMedCrossRef Richter JE. Update on the management of achalasia: balloons, surgery and drugs. Expert Rev Gastroenterol Hepatol. 2008;2(3):435–45.PubMedCrossRef
52.
53.
Zurück zum Zitat Eckardt VF, Kanzler G, Westermeier T. Complications and their impact after pneumatic dilation for achalasia: prospective long-term follow-up study. Gastrointest Endosc. 1997;45(5):349–53.PubMedCrossRef Eckardt VF, Kanzler G, Westermeier T. Complications and their impact after pneumatic dilation for achalasia: prospective long-term follow-up study. Gastrointest Endosc. 1997;45(5):349–53.PubMedCrossRef
54.
Zurück zum Zitat Ghoshal UC, Kumar S, Saraswat VA, Aggarwal R, Misra A, Choudhuri G. Long-term follow-up after pneumatic dilation for achalasia cardia: factors associated with treatment failure and recurrence. Am J Gastroenterol. 2004;99(12):2304–10.PubMedCrossRef Ghoshal UC, Kumar S, Saraswat VA, Aggarwal R, Misra A, Choudhuri G. Long-term follow-up after pneumatic dilation for achalasia cardia: factors associated with treatment failure and recurrence. Am J Gastroenterol. 2004;99(12):2304–10.PubMedCrossRef
55.
Zurück zum Zitat Hulselmans M, Vanuytsel T, Degreef T, et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol. 2010;8(1):30–5.PubMedCrossRef Hulselmans M, Vanuytsel T, Degreef T, et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol. 2010;8(1):30–5.PubMedCrossRef
56.
Zurück zum Zitat Boeckxstaens GE, Annese V, des Varannes SB, et al. Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia. N Engl J Med. 2011;364(19):1807–16.PubMedCrossRef Boeckxstaens GE, Annese V, des Varannes SB, et al. Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia. N Engl J Med. 2011;364(19):1807–16.PubMedCrossRef
57.
Zurück zum Zitat Rohof WO, Salvador R, Annese V, et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology 2013;144(4):718–725; quiz e713–714. Rohof WO, Salvador R, Annese V, et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology 2013;144(4):718–725; quiz e713–714.
58.
Zurück zum Zitat Moonen A, Annese V, Belmans A, et al. Long-term results of the European achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy. Gut. 2016;65(5):732–9.PubMedCrossRef Moonen A, Annese V, Belmans A, et al. Long-term results of the European achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy. Gut. 2016;65(5):732–9.PubMedCrossRef
59.
Zurück zum Zitat Br O, Chang L, Pelligrini CA. Improved outcome after extended gastric myotomy for achalasia. Arch Surgery. 2003;138:490–5.CrossRef Br O, Chang L, Pelligrini CA. Improved outcome after extended gastric myotomy for achalasia. Arch Surgery. 2003;138:490–5.CrossRef
60.
Zurück zum Zitat Richards WO, Torquari A, Holtzman MD, et al. Heller myotomy vs Heller myotomy and Dor fundoplication for achalasia: a prospective randomized double blind study. Ann Surg. 2004;240:405–12.PubMedPubMedCentralCrossRef Richards WO, Torquari A, Holtzman MD, et al. Heller myotomy vs Heller myotomy and Dor fundoplication for achalasia: a prospective randomized double blind study. Ann Surg. 2004;240:405–12.PubMedPubMedCentralCrossRef
61.
Zurück zum Zitat Campos GM, Vittinghoff E, Rabl C, et al. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg. 2009;249:45–57.PubMedCrossRef Campos GM, Vittinghoff E, Rabl C, et al. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg. 2009;249:45–57.PubMedCrossRef
62.
Zurück zum Zitat Werner Y, Hakanson B, Martinek J, et al. Endoscopic or surgical myotomy in patients with idiopathic achalasia. N Engl J Med. 2019;381:2219–29.PubMedCrossRef Werner Y, Hakanson B, Martinek J, et al. Endoscopic or surgical myotomy in patients with idiopathic achalasia. N Engl J Med. 2019;381:2219–29.PubMedCrossRef
63.
Zurück zum Zitat Li J, Lieb J, Gianos JM, et al. Reasons and prevalence of reoperations after esophagomyotomy for achalasia. Surg Laprosc Endo Percutan Tech. 2012;22:392–5. Li J, Lieb J, Gianos JM, et al. Reasons and prevalence of reoperations after esophagomyotomy for achalasia. Surg Laprosc Endo Percutan Tech. 2012;22:392–5.
64.
Zurück zum Zitat Guo JP, Gilman PB, Thomas RM, et al. Barrett’s esophagus and achalasia. J Clin Gastroenterol. 2002;34:439–43.PubMedCrossRef Guo JP, Gilman PB, Thomas RM, et al. Barrett’s esophagus and achalasia. J Clin Gastroenterol. 2002;34:439–43.PubMedCrossRef
65.
Zurück zum Zitat Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010;42(4):265–71.PubMedCrossRef Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010;42(4):265–71.PubMedCrossRef
66.
Zurück zum Zitat Stavropoulos SN, Friedel D, Modayil R, Iqbal S, Grendell JH. Endoscopic approaches to treatment of achalasia. Therap Adv Gastroenterol. 2013;6(2):115–35.PubMedPubMedCentralCrossRef Stavropoulos SN, Friedel D, Modayil R, Iqbal S, Grendell JH. Endoscopic approaches to treatment of achalasia. Therap Adv Gastroenterol. 2013;6(2):115–35.PubMedPubMedCentralCrossRef
67.
Zurück zum Zitat Kahrilas PJ, Katzka D, Richter JE. Clinical practice update: the use of per-oral endoscopic myotomy in achalasia: expert review and best practice advice from the AGA Institute. Gastroenterology. 2017;153(5):1205–11.PubMedCrossRef Kahrilas PJ, Katzka D, Richter JE. Clinical practice update: the use of per-oral endoscopic myotomy in achalasia: expert review and best practice advice from the AGA Institute. Gastroenterology. 2017;153(5):1205–11.PubMedCrossRef
68.
Zurück zum Zitat Haito-Chavez Y, Inoue H, Beard KW, et al. Comprehensive analysis of adverse events associated with per oral endoscopic myotomy in 1826 patients: an international multicenter study. Am J Gastroenterol. 2017;112(8):1267–76.PubMedCrossRef Haito-Chavez Y, Inoue H, Beard KW, et al. Comprehensive analysis of adverse events associated with per oral endoscopic myotomy in 1826 patients: an international multicenter study. Am J Gastroenterol. 2017;112(8):1267–76.PubMedCrossRef
69.
Zurück zum Zitat Patel KS, Calixte R, Modayil RJ, Friedel D, Brathwaite CE, Stavropoulos SN. The light at the end of the tunnel: a single-operator learning curve analysis for per oral endoscopic myotomy. Gastrointest Endosc. 2015;81(5):1181–7.PubMedCrossRef Patel KS, Calixte R, Modayil RJ, Friedel D, Brathwaite CE, Stavropoulos SN. The light at the end of the tunnel: a single-operator learning curve analysis for per oral endoscopic myotomy. Gastrointest Endosc. 2015;81(5):1181–7.PubMedCrossRef
70.
Zurück zum Zitat Liu Z, Zhang X, Zhang W, et al. Comprehensive evaluation of the learning curve for peroral endoscopic myotomy. Clin Gastroenterol Hepatol 2018;16(9):1420–1426 e1422. Liu Z, Zhang X, Zhang W, et al. Comprehensive evaluation of the learning curve for peroral endoscopic myotomy. Clin Gastroenterol Hepatol 2018;16(9):1420–1426 e1422.
71.
Zurück zum Zitat Ponds FA, Fockens P, Lei A, et al. Effect of peroral endoscopic myotomy vs pneumatic dilation on symptom severity and treatment outcomes among treatment-naive patients with achalasia: a randomized clinical trial. JAMA. 2019;322(2):134–44.PubMedPubMedCentralCrossRef Ponds FA, Fockens P, Lei A, et al. Effect of peroral endoscopic myotomy vs pneumatic dilation on symptom severity and treatment outcomes among treatment-naive patients with achalasia: a randomized clinical trial. JAMA. 2019;322(2):134–44.PubMedPubMedCentralCrossRef
72.
Zurück zum Zitat Andolfi C, Fisichella PM. Meta-analysis of clinical outcome after treatment for achalasia based on manometric subtypes. Br J Surg. 2019;106(4):332–41.PubMedCrossRef Andolfi C, Fisichella PM. Meta-analysis of clinical outcome after treatment for achalasia based on manometric subtypes. Br J Surg. 2019;106(4):332–41.PubMedCrossRef
73.
Zurück zum Zitat Repici A, Fuccio L, Maselli R, et al. GERD after per-oral endoscopic myotomy as compared with Heller's myotomy with fundoplication: a systematic review with meta-analysis. Gastrointest Endosc 2018;87(4):934–943 e918. Repici A, Fuccio L, Maselli R, et al. GERD after per-oral endoscopic myotomy as compared with Heller's myotomy with fundoplication: a systematic review with meta-analysis. Gastrointest Endosc 2018;87(4):934–943 e918.
74.
Zurück zum Zitat Ichkhanian Y, Benias P, Khashab MA. Case of early Barrett cancer following peroral endoscopic myotomy. Gut. 2019;68(12):2107–10.PubMedCrossRef Ichkhanian Y, Benias P, Khashab MA. Case of early Barrett cancer following peroral endoscopic myotomy. Gut. 2019;68(12):2107–10.PubMedCrossRef
75.
Zurück zum Zitat Ratuapli SK, Crowell MD, Dibuse JK, et al. Opioid-induced esophageal dysfunction (OIED) in patients on chronic opioids. Am J Gastroenterol. 2015;110:979–84.PubMedCrossRef Ratuapli SK, Crowell MD, Dibuse JK, et al. Opioid-induced esophageal dysfunction (OIED) in patients on chronic opioids. Am J Gastroenterol. 2015;110:979–84.PubMedCrossRef
76.
Zurück zum Zitat Babari A, Szabo A, Shad S, et al. Chronic daily opioid exposure is associated with dysphagia, EGJ outflow obstruction and disordered perstalsis. Neurogastroenterol Motil. 2019;31:e13601. Babari A, Szabo A, Shad S, et al. Chronic daily opioid exposure is associated with dysphagia, EGJ outflow obstruction and disordered perstalsis. Neurogastroenterol Motil. 2019;31:e13601.
77.
Zurück zum Zitat Ortiz V, Garcia-Campo M, Saez-Gonzales E, et al. A concise review of opioid-induced esophageal dysfunction: Is this a new clinical entity? Dis Esophagus. 2018;31:1–6.CrossRef Ortiz V, Garcia-Campo M, Saez-Gonzales E, et al. A concise review of opioid-induced esophageal dysfunction: Is this a new clinical entity? Dis Esophagus. 2018;31:1–6.CrossRef
78.
Zurück zum Zitat Snyder DL, Crowell MD, Horsley-Silva J, et al. Opioid-induced esophageal dysfunction: differential effects of type and dose. Am J Gastroenterol. 2019;114:1464–9.PubMedCrossRef Snyder DL, Crowell MD, Horsley-Silva J, et al. Opioid-induced esophageal dysfunction: differential effects of type and dose. Am J Gastroenterol. 2019;114:1464–9.PubMedCrossRef
79.
Zurück zum Zitat Richter JE. Tailoring therapy for achalasia. Gastroenterol and Hepatol. 2020;16:249–56. Richter JE. Tailoring therapy for achalasia. Gastroenterol and Hepatol. 2020;16:249–56.
80.
Zurück zum Zitat Lacy BE, Weiser K, Kennedy A. Botulinum toxin and gastrointestinal tract disorders: pancea, placebo or pathway to the future. Gastroenterol Hepatol. 2008;5:283–95. Lacy BE, Weiser K, Kennedy A. Botulinum toxin and gastrointestinal tract disorders: pancea, placebo or pathway to the future. Gastroenterol Hepatol. 2008;5:283–95.
81.
Zurück zum Zitat Jacobs J, Richter JE. Opening the bird’s beak: tips and tricks for effective pneumatic dilation for achalasia. Am J Gastroenterol. 2016;111(2):157–8.PubMedCrossRef Jacobs J, Richter JE. Opening the bird’s beak: tips and tricks for effective pneumatic dilation for achalasia. Am J Gastroenterol. 2016;111(2):157–8.PubMedCrossRef
Metadaten
Titel
Update on the Diagnosis and Treatment of Achalasia
verfasst von
Wojciech Blonski
Samuel Slone
Joel E. Richter
Publikationsdatum
18.05.2022
Verlag
Springer US
Erschienen in
Dysphagia / Ausgabe 2/2023
Print ISSN: 0179-051X
Elektronische ISSN: 1432-0460
DOI
https://doi.org/10.1007/s00455-022-10435-3

Neu im Fachgebiet HNO

Die Herausforderung des Burning-Mouth-Syndroms meistern

Das Burning-Mouth-Syndrom geht mit einem hohen Leidensdruck einher und führt oft zu einer frustranen Odyssee durch verschiedene Arztpraxen. Lässt sich keine ursächliche Grunderkrankung dingfest machen, können verschiedene symptomatische Behandlungsansätze versucht werden. 

Kopf-Hals-Tumoren: Wann eine Therapiedeeskalation und wann eine Prähabilitation?

Karzinome im Kopf-Hals-Bereich und deren Behandlung bedeuten eine erhebliche Belastung für die Betroffenen. Umso wichtiger sind Konzepte beispielsweise zur Therapiedeeskalation bei HPV-positiven Oropharynxkarzinomen oder zur Prähabilitation.

Welchen Stellenwert hat die Tonsillektomie?

Immer wieder wird kontrovers diskutiert, ob und wann eine Tonsillenchirurgie bei rezidivierender akuter Tonsillitis indiziert ist. Evidenzbasierte Empfehlungen erleichtern die praktische Entscheidungsfindung.

Neue endoskopische Wege beim Globusgefühl

Ein „Kloß im Hals“ kann viele Ursachen haben. Moderne Versorgungskonzepte des Globusgefühls sollten eine umfassende Abklärung aus verschiedenen „Blickwinkeln“ und eine interdisziplinäre Behandlung umfassen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.